Partners

To be a successful drug discovery organisation it is crucial to have partners who are able to bring high-quality skills and resources that complement your own.

Domainex has an outstanding record of providing its clients with expertise and technology that has led to the cloning and expression of challenging molecular targets, and to the design and synthesis of hits, leads, and development candidates. We have helped many clients to move their organisations forward by bringing their projects to the point where they have been able to attract further funding (from investors or grants), or have been able to progress compounds into clinical studies. Our previous clients include UCB, Vertex, Syngenta, Novartis, Ark Therapeutics, MRC, Cancer Research Technology, and a large number of universities and research institutes.

Recently Domainex has also begun to construct its own pipeline of drug discovery targets. These are generally targets which are challenging and therefore well suited to our skills and technologies. Domainex is interested in exploring strategic drug discovery collaborations based upon its oncology pipeline.

For further partnering information and details contact business@domainex.co.uk